10 million people in UK given first vaccine dose but infections still “alarmingly high” – BBC News

About This Source - BBC News

The video item below is a piece of English language content from BBC News. The British Broadcasting Corporation (BBC) is a British public service broadcaster funded by the UK Government, and British license fee payers. Its headquarters are at Broadcasting House in Westminster, London.

Recent from BBC News:

  • Russia moves ailing Putin critic Navalny to prison hospital – BBC News
  • India added to UK travel ‘red list’ – BBC News
  • Nasa successfully flies small helicopter on Mars – BBC News
  • BBC News published this video item, entitled “10 million people in UK given first vaccine dose but infections still “alarmingly high” – BBC News” – below is their description.

    More than 10 million people across the UK have received at least one vaccination for coronavirus as part of the biggest programme of its kind in the history of the National Health Service.

    It’s a major milestone in the race to control the faster-spreading variants of the virus. However medical experts say the UK’s infection levels are still “alarmingly high” and many people are still dying from Covid-19.

    The pharma giant AstraZeneca and Oxford University say they hope to have created a “next generation” vaccine by the autumn, to protect against some new variants of the disease.

    Huw Edwards presents BBC News at Ten reporting by political editor Laura Kuenssberg, medical editor Fergus Walsh and health editor Hugh Pym.

    BBC News YouTube Channel

    Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

    In This Story: AstraZeneca

    AstraZeneca plc/AB (LON: AZN) is a British-Swedish multinational pharmaceutical and biopharmaceutical company with its headquarters in Cambridge, United Kingdom and Södertälje, Sweden. Its R&D is concentrated in Cambridge in United Kingdom, Södertälje in Sweden, and Maryland and Toronto in North America.

    3 Recent Items: AstraZeneca

  • Ontario, Alberta lower minimum age for AstraZeneca shot to 40
  • The AstraZeneca vaccine could be fast-tracked for Australians aged over 50 | 7NEWS
  • Argentina receives AstraZeneca jabs amid anti-lockdown protests
  • In This Story: COVID-19

    Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.

    Symptoms of coronavirus

    The main symptoms of coronavirus are:

    • a persistent new cough (non productive, dry)
    • a high temperature (e.g. head feels warm to the touch)
    • shortness of breath (if this is abnormal for the individual, or increased)

    Latest News about Covid-19

    Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.

    5 Recent Items: COVID-19

  • “Our hearts are broken” – Lorna Brooke tributes pour in on Sky Sports Racing
  • LIVE: Greta Thunberg joins the WHO at its COVID briefing
  • Greta Thunberg and the WHO’s Tedros Adhanom hold virtual talk on climate crisis and COVID
  • Media briefing on COVID-19 and climate change with Dr Tedros and Greta Thunberg
  • Alex Salmond to RT: Scottish Independence is for the here and now – not for the hereafter
  • In This Story: Oxford University

    The University of Oxford is a collegiate research university in Oxford, Oxfordshire, England. There is evidence of teaching as early as 1096, making it the oldest university in the English-speaking world and the world’s second-oldest university in continuous operation.

    4 Recent Items: Oxford University

  • Latest research on vaccine side effects, immune reaction and thrombosis risks | COVID-19 Special
  • AstraZeneca vaccine trial in children halted as blood clot link investigated
  • Feeling anxious about meeting people as lockdown eases? Here’s four tips | ITV News
  • Will the UK’s new rules stop illegal immigration? | Inside Story
  • Leave a Comment